Is very low dose hydrochlorothiazide combined with candesartan effective in uncontrolled hypertensive patients?

Blood Pressure Monitoring

Volumn 15, Issue 6, 2010, Pages 308-311

  Eguchi, Kazuo ^a   Hoshide, Satoshi ^a   Kabutoya, Tomoyuki ^a   Shimada, Kazuyuki ^a   Kario, Kazuomi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

ambulatory blood pressure; candesartan; combination therapy; hydrochlorothiazide; morning blood pressure; sleep blood pressure; very low dose

Indexed keywords

CANDESARTAN; HYDROCHLOROTHIAZIDE; URIC ACID;

ADD ON THERAPY; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY SIZE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LOW DRUG DOSE; MAINTENANCE THERAPY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; UNCONTROLLED HYPERTENSION; URIC ACID BLOOD LEVEL; URINALYSIS;

AGED; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BLOOD PRESSURE MONITORING, AMBULATORY; BODY MASS INDEX; CIRCADIAN RHYTHM; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; SLEEP; TETRAZOLES;

EID: 78650306315     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBP.0b013e32833f4be7     Document Type: Article

References (10)

1. White WB, Calhoun DA, Samuel R, Taylor AA, Zappe DH, Purkayastha D. Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? The valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trial. J Clin Hypertens (Greenwich) 2008; 10:450-458.
2. Karlson BW, Zetterstrand S, Olofsson B, Elmfeldt D. A dose-response analysis of candesartan-hydrochlorothiazide combination therapy in patients with hypertension. Blood Press 2009; 18:149-156.
3. Ziegler MG, Lernhardt E, Solt-Buzsaki V. Dose response to hydrochlorothiazide in hypertensives receiving a calcium channel blocker. Clin Exp Hypertens A 1988; 10:791-800.
4. Jounela AJ, Lilja M, Lumme J, Mörlin C, Hoyem A, Wessel-Aas T, et al. Relation between low dose of hydrochlorothiazide, antihypertensive effect and adverse effects. Blood Press 1994; 3:231-235.
5. Chrysant SG, Fagan T, Glazer R, Kriegman A. Effects of benazepril and hydrochlorothiazide, given alone and in low-and high-dose combinations, on blood pressure in patients with hypertension. Arch Fam Med 1996; 5:1 7-24.
6. Guul SJ, Os I, Jounela AJ. The efficacy and tolerability of enalapril in a formulation with a very low dose of hydrochlorothiazide in hypertensive patients resistant to enalapril monotherapy. Am J Hypertens 1995; 8:727-731.
7. Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipperto dipper in essential hypertension. Circulation 1999; 100:1635-1638.
8. Xavier P-S. Treatment of the obese hypertensive patients. In: Izzo JL, Sica DA, Black HR, editors. Hypertension primer: the essentials of high blood pressure. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. pp. 526-528.
9. Oparil S, Abate N, Chen E, Creager MA, Galet V, Jia G, et al. A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension. Curr Med Res Opin 2008; 24:1101-1114.
10. Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med 2008; 14:1370-1376.